Feasibility of Telemedicine Medical Abortion
TelAbortion: Medical Abortion by Direct-to-patient Telemedicine and Mail
1 other identifier
observational
413
1 country
15
Brief Summary
This pilot study is designed to obtain data on the safety, acceptability, and feasibility of providing abortion by direct-to-patient telemedicine and mail.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2020
Shorter than P25 for all trials
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedFirst Submitted
Initial submission to the registry
October 19, 2020
CompletedFirst Posted
Study publicly available on registry
October 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedFebruary 4, 2022
October 1, 2020
1 year
October 19, 2020
February 3, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants with adverse events
2 years
Study Arms (1)
Pregnant people
Interventions
Eligibility Criteria
People seeking abortion
You may qualify if:
- desires abortion
You may not qualify if:
- medically ineligible for procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (15)
Planned Parenthood of the Rocky Mountains
Denver, Colorado, 80207, United States
Carafem
Washington D.C., District of Columbia, 20815, United States
Carafem
Atlanta, Georgia, 30309, United States
The University of Hawaii Women's Options Centers
Honolulu, Hawaii, 96826, United States
Carafem
Skokie, Illinois, 60076, United States
Emma Goldman Clinic
Iowa City, Iowa, 52245, United States
Maine Family Planning
Augusta, Maine, 04332, United States
Carafem
Chevy Chase, Maryland, 20815, United States
Maine Family Planning
Boston, Massachusetts, 02134, United States
Planned Parenthood Minnesota, North Dakota, South Dakota
Saint Paul, Minnesota, 55114, United States
Planned Parenthood of Montana
Billings, Montana, 59102, United States
Planned Parenthood of the Rocky Mountains
Albuquerque, New Mexico, 80207, United States
Maine Family Planning
New York, New York, 04332, United States
Planned Parenthood Columbia Willamette
Portland, Oregon, 97212, United States
Planned Parenthood Columbia Willamette
Vancouver, Washington, 97212, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth Raymond, MD, MPH
Gynuity Health Projects
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 19, 2020
First Posted
October 23, 2020
Study Start
October 1, 2020
Primary Completion
October 1, 2021
Study Completion
October 1, 2021
Last Updated
February 4, 2022
Record last verified: 2020-10